相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。EXTERNAL PELVIC AND VAGINAL IRRADIATION VERSUS VAGINAL IRRADIATION ALONE AS POSTOPERATIVE THERAPY IN MEDIUM-RISK ENDOMETRIAL CARCINOMA-A PROSPECTIVE RANDOMIZED STUDY
Bengt Sorbe et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Understanding obesity and endometrial cancer risk: opportunities for prevention
Rosemarie E. Schmandt et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2011)
Revised FIGO Staging System for Endometrial Cancer
Sharyn N. Lewin
CLINICAL OBSTETRICS AND GYNECOLOGY (2011)
Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group
Amit M. Oza et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study
Carol Aghajanian et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
A Phase 2 Study of the Oral Mammalian Target of Rapamycin Inhibitor, Everolimus, in Patients With Recurrent Endometrial Carcinoma
Brian M. Slomovitz et al.
CANCER (2010)
Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer - Results from two randomised studies
Thomas Hogberg et al.
EUROPEAN JOURNAL OF CANCER (2010)
A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: A trial of the Chicago, PMH, and California Phase II Consortia
Halla S. Nimeiri et al.
GYNECOLOGIC ONCOLOGY (2010)
Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study
Gini F. Fleming et al.
GYNECOLOGIC ONCOLOGY (2010)
Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial
R. A. Nout et al.
LANCET (2010)
A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study
Howard D. Homesley et al.
GYNECOLOGIC ONCOLOGY (2009)
Intravaginal Brachytherapy in FIGO Stage I Low-Risk Endometrial Cancer A Controlled Randomized Study
Bengt Sorbe et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
Phase II Trial of Ixabepilone As Second-Line Treatment in Advanced Endometrial Cancer: Gynecologic Oncology Group Trial 129-P
Don S. Dizon et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results,, systematic review, and meta-analysis
P. Blake et al.
LANCET (2009)
A randomized phase II study of ixabepilone (BMS-247550) given daily x 5 days every 3 weeks or weekly in patients with metastatic or recurrent squamous cell cancer of the head and neck: an Eastern Cooperative Oncology Group study
B. A. Burtness et al.
ANNALS OF ONCOLOGY (2008)
Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells
G. E. Konecny et al.
BRITISH JOURNAL OF CANCER (2008)
Preclinical discovery of ixabepilone, a highly active antineoplastic agent
Francis Y. F. Lee et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Synergistic Antitumor Activity of Ixabepilone (BMS-247550) Plus Bevacizumab in Multiple In vivo Tumor Models
Francis Y. F. Lee et al.
CLINICAL CANCER RESEARCH (2008)
Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: A Japanese Gynecologic Oncology Group study
Nobuyuki Susumu et al.
GYNECOLOGIC ONCOLOGY (2008)
Phase II study of erlotinib in recurrent or metastatic endometrial cancer: NCICIND-148
Amit M. Oza et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
Andrew G. Renehan et al.
LANCET (2008)
Clinical Development of Ixabepilone and Other Epothilones in Patients with Advanced Solid Tumors
Edgardo Rivera et al.
ONCOLOGIST (2008)
Clinical and biological significance of vascular endothelial growth factor in endometrial cancer
Aparna A. Kamat et al.
CLINICAL CANCER RESEARCH (2007)
Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study
Gillian K. Reeves et al.
BRITISH MEDICAL JOURNAL (2007)
Efficacy and safety of ixabepilone (BMS-247550) in a phase II study of patients with advanced breast cancer resistant to an anthracycline, a taxane, and capecitabine
Edith A. Perez et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, as first-line therapy in patients with metastatic breast cancer previously treated with anthracycline chemotherapy
Henri Roche et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in patients with taxane-resistant metastatic breast cancer
Eva Thomas et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase II clinical trial of the epothilone B analog, ixabepilone, in patients with non-small-cell lung cancer whose tumors have failed first-line platinum-based chemotherapy
Johan Vansteenkiste et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Systemic chemotherapy for uterine carcinoma: Metastatic and adjuvant
Gini F. Fleming
JOURNAL OF CLINICAL ONCOLOGY (2007)
Final results of a multi-center, double-blind, randomized, placebo-controlled phase II study to assess the efficacy of MAGE-A3 immunotherapeutic as adjuvant therapy in stage IB/II non-small cell lung cancer (NSCLC)
J. Vansteenkiste et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Updated results of the combined analysis of NCCTG N9831 and NSABP B-31 adjuvant chemotherapy with/without trastuzumab in patients with HER2-positive breast cancer
E. A. Perez et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Molecular and pathologic aspects of endometrial carcinogenesis
Jonathan L. Hecht et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial
R. Maggi et al.
BRITISH JOURNAL OF CANCER (2006)
Comparison of uterine malignancies that develop during and following tamoxifen therapy
Sarah E. Ferguson et al.
GYNECOLOGIC ONCOLOGY (2006)
Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: A gynecologic oncology group study
ME Randall et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Ixabepilone (epothilone B analogue BMS-247550) is active in chemotherapy-naive patients with hormone-refractory prostate cancer: A southwest oncology group trial S0111
M Hussain et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancer
MD Galsky et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study
HM Keys et al.
GYNECOLOGIC ONCOLOGY (2004)
Phase III randomized trial of doxorubicin plus cisplatin versus doxorubicin+24-h paclitaxel plus filgrastim in endometrial carcinoma: a Gynecologic Oncology Group study
GF Fleming et al.
ANNALS OF ONCOLOGY (2004)
Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study
CW Whitney et al.
GYNECOLOGIC ONCOLOGY (2004)
Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study
JV Fiorica et al.
GYNECOLOGIC ONCOLOGY (2004)
Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: A gynecologic oncology group study
GF Fleming et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: A gynecologic oncology group study
JT Thigpen et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review
PT Ramirez et al.
GYNECOLOGIC ONCOLOGY (2004)
Activity of paclitaxel as second-line chemotherapy in endometrial carcinoma: a Gynecologic Oncology Group study
S Lincoln et al.
GYNECOLOGIC ONCOLOGY (2003)
Expression of vascular endothelial growth factors (VEGF-A/VEGF-1 and VEGF-C/VEGF-2) in postmenopausal uterine endometrial carcinoma
M Hirai et al.
GYNECOLOGIC ONCOLOGY (2001)
Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: A gynecologic oncology group study
T Thigpen et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Prognostic significance of vascular endothelial growth factor and its receptors in endometrial carcinoma
Y Yokoyama et al.
GYNECOLOGIC ONCOLOGY (2000)
Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma:: multicentre randomised trial
CL Creutzberg et al.
LANCET (2000)
分享论文
